Health1st AI Logo

Solutions · Emerging Biotech

Run a credible first trial before you can staff one.

You have the molecule and the runway math, not a clinical operations department — yet. Health1st AI hands a small team an entire capability out of the box — build, data, biostatistics, and eTMF — so your first program looks and holds up like a seasoned sponsor's, without hiring every function first.

What you own

Your goals

  • Launch a first trial credibly and quickly
  • Avoid over-hiring before the program is de-risked
  • Produce submission-quality deliverables from day one
  • Preserve cash while maintaining rigor

We know how this feels

The pains we remove

This is the trial your company is riding on, and you're running it with a team small enough to fit in one room — every decision feels like it's yours alone.

  • There's no in-house data management, biostatistics, or medical writing yet — and the trial won't wait for you to hire it
  • Every function is a build-or-buy call made under time pressure, with real money on each one
  • You're carrying investor and regulator scrutiny with a team small enough to fit in one room
  • Cash and runway make every vendor invoice a decision you have to defend

And the part no one says out loud:

  • Burning months and cash on a first trial that a regulator or acquirer later picks apart for sloppiness you couldn't afford to catch
  • A quality or compliance gap surfacing at diligence — the moment your credibility, and the raise, is on the line

Where the agents fit

Every pain, matched to the agent that removes it

The grind you just read isn't abstract — each piece of it already has an agent assigned. Here's which one picks up which fight, so you can see exactly where the help lands before you commit to anything.

Your agentic workforce

The agents that help

These feature agents map most directly to emerging biotech. Enable the ones you need, per study and per deliverable, and expand over time.

Outcomes

What good looks like

Quantified targets we build toward with each engagement.

Full stack
Build → data → stats → eTMF
70%
Less manual effort per deliverable
Day one
Submission-quality outputs

Figures shown are pre-launch targets based on internal benchmarks, not guaranteed outcomes.

Every output is grounded, reviewed, and inspection-ready

We're five people and one asset. This let us run a trial that stands up to diligence without hiring a department we couldn't afford yet — the deliverables look like they came from a company ten times our size.
Head of Clinical Development, early-stage biotech

Illustrative — representative of the workflows we build toward during our pre-launch pilot.

No pressure, straight answers

What you're probably wondering

The doubts that usually surface before a team like yours says yes — answered plainly, including the places where the honest answer is a limit rather than a promise.

Let's see it on your study

See it run on one of your own studies — no pressure, no obligation, and honest answers, including on the limits. We will walk emerging biotech through exactly what stays under your control.

← Back to all solutions (by organization and more)